Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends E.U. approval of Alprolix to treat hemophilia B

Feb. 29, 2016

EMA CHMP issues positive opinion for ixekizumab for plaque psoriasis

Feb. 29, 2016

Gilead's Descovy receives positive CHMP opinion for HIV infection

Feb. 29, 2016

EMA grants orphan drug designation to TNT-009 for autoimmune hemolytic anemia

Feb. 26, 2016

European orphan drug designation for EYS-606 in refractory noninfectious uveitis

Feb. 26, 2016

EMA approves development strategy for Mologen's lefitolimod

Feb. 25, 2016

EMA creates Zika virus task force, HemispheRx announces its approach

Feb. 10, 2016

EMA confirms positive risk-benefit ratio of Xarelto for prevention of stroke in patients with AF

Feb. 8, 2016

EMA committee recommends approval of Coagadex to treat FX deficiency

Feb. 1, 2016

EMA committee backs approval of Uptravi for PAH

Feb. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...